By Dr. Liji Thomas, MD Stopping popular GLP-1 weight-loss drugs may reverse much of their benefit within a year, according to a large modeling analysis, raising questions about how long patients may ...

The rising star's campaign offers some clues to solving a major Democratic problem.

The professor tasked with overseeing the attorney general’s course review warned UF’s law school dean he was willing to “bend ...

ProEssentials v10 introduces pe_query.py, the only charting AI tool that validates code against the compiled DLL binary ...

Accel Entertainment is rated 'Buy' with a new price target midpoint of $16.60, reflecting a 27.7% upside through FY 2027.

Peloton (PTON) trades at 4.5x free cash flow with strong deleveraging and FY26 upside—explore guidance, churn risks, and ...

Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.

Operation Epic Fury costs nearly $900 million per day, driven by the large expenditure of munitions. Because most of this is ...

India's HPV vaccine, Cervavac, faces delays for inclusion in immunization programs due to ongoing studies and competition ...

Explore how agentic AI is transforming universities, urging teachers to adapt their roles for enhanced student engagement and ...

Baltimore Sun Orioles reporter Jacob Calvin Meyer will answer fans’ questions throughout Orioles spring training and the season. Here are JCM’s thoughts on several questions from readers. (Editor’s ...

Worrying about a secret you hold? A new study finds you aren't the only one, and doing so can have consequences for your well-being.